Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the D... by Akihiko Koshino, Brendon L. Neuen, Niels Jongs, Carol Pollock, Peter J. Greasley, Eva-Marie Andersson, Ann Hammarstedt, Cecilia Karlsson, Anna Maria Langkilde, Takashi Wada, Hiddo J.L. Heerspink

Get full text

Effects of Dapagliflozin in Patients with Membranous Nephropathy by Glenn M. Chertow, Hiddo Lambers Heerspink, Patrick B. Mark, Jamie P. Dwyer, Michal Nowicki, David C. Wheeler, Ricardo Correa-Rotter, Peter Rossing, Robert D. Toto, Anna Maria Langkilde, Niels Jongs

Get full text

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial by Glenn M. Chertow, Ricardo Correa‐Rotter, Priya Vart, Niels Jongs, John J. V. McMurray, Peter Rossing, Anna Maria Langkilde, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J. L. Heerspink

Get full text